Pacira Two-Year Efficacy Data in Knee Osteoarthritis

 -- PCRX-201 demonstrated two years of clinically meaningful improvements in pain, stiffness and function across all structural severity subgroups, including advanced disease --

-- Study Findings Presented at 2025 OARSI World Congress--

https://www.globenewswire.com/news-release/2025/04/28/3069138/0/en/Pacira-BioSciences-Announces-Two-Year-Efficacy-Data-Following-a-Single-Local-Administration-of-PCRX-201-in-Patients-with-Mild-to-Severe-Osteoarthritis-of-the-Knee.html